Aktis Oncology, Inc. Stock Split Ratio
Aktis Oncology, Inc. (AKTS) had Stock Split Ratio of 26.30% as of 2026-02-01, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-13
- 2026-02-01: Stockholders' Equity Note, Stock Split, Conversion Ratio 26.30%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2026-02-01 | 26.30% 10-Q · filed 2026-08-13 |